AL NOOR HOSPITALS
Numis has maintained a “buy” rating for the Abu Dhabi-based healthcare provider. The firm believes Al Noor will be able to sustain mid to high-teens revenue growth over the next three years, driven by doctor recruitment, capacity expansion and maturation of new doctors' practices.
Westhouse Securities has maintained a “buy” rating in a relatively neutral report (disappointing re exploration but positive on appraisal). However, the market appears to be more focused on short-term cash flow generation and balance sheet sustainability at the moment.